AGMB
AgomAb Therapeutics NV
11.10$
+5.4%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q3 25 | Q4 25 | Q1 26 |
|---|---|---|---|---|
| 0.0 | 0.0 | 0.0 | – | |
| 11 | 13 | 14 | 11 | |
| 1.4 | 2.6 | 3.3 | 1.4 | |
| 12 | 15 | 17 | 12 | |
| -12 | -15 | -17 | -12 | |
| 0.2 | 0.1 | 0.1 | – | |
| -12 | -18 | -17 | -12 | |
| 0.0 | – | – | 0.0 | |
| -12 | -18 | -17 | -12 | |
| -12 | -18 | -18 | -12 |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.